The Native Antigen Company expands range of Norovirus-like particles
Oxford, UK: The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has announced the expansion of its norovirus-like particle range, with the addition of six new reagents, including four which are unique to the market. These virus-like…
Learning through ‘guided’ play can be as effective as adult-led instruction
Play-based learning may also have a more positive effect on younger children’s acquisition of important early maths skills compared with traditional, direct instruction.
Trust backs trial into treatment for severe hearing loss
Addenbrooke’s Hospital is to support a national study into the best treatment options for adults living with severe hearing loss.
St Ives travel preferences revealed as transport panel approves next steps for unified A141 improvement scheme
At its first meeting of 2022, the Transport and Infrastructure Committee of the Cambridgeshire & Peterborough Combined Authority heard how bypass and active travel options for St Ives got the thumbs-up from the public.
Abcam in Glassdoor’s top 5 ‘best places to work in the UK’ for second consecutive year
Abcam, a global innovator empowering life science researchers with high-quality biological reagents and tools critical to research, drug discovery and diagnostics, has received the Employees’ Choice Award 2022, recognising Abcam in Glassdoor’s Best Places to Work in the UK. Abcam is the first biotech company to be ranked in the top five for two years in a row1.
French law firm Lerins & BCW deploys Luminance’s AI for contract review and knowledge management
London, UK, and Paris, France - Leading French business law firm, Lerins & BCW, has announced its adoption of Luminance’s next-generation artificial intelligence to enhance its contract review and knowledge management capabilities.
Domino collaborates with Cambridge University on ground-breaking inks research
A Cambridge company is partnering with academia to solve a long-standing issue in its sector which will deliver benefits to customers and enable further improvements for the coding and marking industry as a whole.
Respiratory devices: trends to watch in 2022
Attending the Drug Delivery to the Lungs (DDL) conference is always an exciting time, says Team Consulting.
What the EU is trying to change in the years ahead
The North Sea Region Programme of the European Union announced its first call for Projects under the new 2021-2027 programme on 16 December, 2021. EFEC is working with University of Groningen to develop a project proposal to speed up technology transfer in the circular economies of rural areas.
NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics
NeoCura Bio-Medical Technology Co Ltd, a leading RNA-based drug research and development company in China, and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, have announced an oncology drug discovery research collaboration.
Groups invited to apply for Area Committee and Platinum Jubilee grants
Groups delivering projects that benefit local communities could be eligible for grants from Cambridge City Council.
Board reform is subject of new book
Improving board effectiveness requires a focus on the relationship aspect of boards as well as their structure, says a new book by Dr Philip Stiles of Cambridge Judge.
IDTechEx discusses the potential of printed piezoelectric sensors
Printed pressure sensors are a well-established technology, having been used for applications such as car occupancy sensors, electric pianos, and some medical devices. To date, such sensors have always been based on piezoresistive materials, in which applying pressure increases conductivity. In contrast, despite extensive R&D printed piezoelectric sensors, in which applying pressure produces…
NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics
Shenzhen, China and Cambridge, UK: NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in China, and PhoreMost Limited (PhoreMost), the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, have announced an oncology drug discovery research collaboration.
Breathe Technology supports your IT needs
Breathe Technology wants to reach out to offer assistance as one of the region’s leading IT & Comms providers.
BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies
BioNTech SE (Nasdaq: BNTX) and Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, announced that they have entered a multi-target discovery collaboration to develop novel immunotherapies for the treatment of patients with cancer and other diseases. The initial term of the discovery collaboration is three years.
Illumina delivers 2021 results ahead of expectations
Multiple innovative partnerships with healthcare companies, research institutions, and multiomic developers, along with new groundbreaking technologies, including a new SBS chemistry and long-read capabilities, position Illumina to accelerate genomic adoption and improve human health globally.
H.E.L Group expands operations in India
H.E.L India opening further strengthens H.E.L's global presence with regional hub-based service and customer support. Expansion will focus on supporting high growth industries in India, including biotechnology, process safety, and pharmaceutical industries
Record breaking IPO activity in 2021 but headwinds could threaten IPO success in 2022
London witnessed a record number of IPOs in 2021 with 121 IPOs, the highest since 2007, raising total funds of £16.3bn, according to EY’s latest market tracker, IPO Eye.
Cambridge launches new Leverhulme Centre for Life in the Universe
With a £10 million grant awarded by the Leverhulme Trust*, the University of Cambridge is to establish a new research centre dedicated to exploring the nature and extent of life in the universe.
Professor Sharon Peacock awarded the MRC Millennium Medal 2021
Professor Sharon Peacock, from the University of Cambridge and the COVID-19 Genomics UK (COG-UK) Consortium, has been awarded the MRC Millennium Medal 2021.
Medovate to exhibit and demonstrate award winning SAFIRA® technology at Arab Health 2022
Medovate, a dynamic Cambridge based medical device development company, will be showcasing award winning NHS innovation at the upcoming Arab Health 2022 event at the Dubai World Trade Centre on 24 - 27 January.
Prism advises on acquisition of agricultural silage covers specialist
The Prism team is delighted to announce that they have advised family-owned investment company, Milbank Group, on its acquisition of Bruno Rimini Limited (t/a Silostop).
Plan early on how your product will be used to solve your R&D challenges
Breaking new frontiers is foremost on your mind. But don’t let it come at a cost to other areas of your business.
Tame your computer - with follow-up flags
In her regular series for Cambridge Network members, software training expert Karen Roem offers handy tips to help you 'Tame your computer'. This week she describes how to add follow-up reminder text and a column to an email (Microsoft Outlook).